Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 200,000 shares at $55.48 ($11.1M) on 2020-07-15, disclosed to the SEC on 2020-07-17.
Open-market sale of $11.1M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.48 | 25,599 | $1.4M | 12.7% |
| 2 | $55.48 | 25,597 | $1.4M | 12.7% |
| 3 | $55.48 | 25,597 | $1.4M | 12.7% |
| 4 | $55.48 | 25,599 | $1.4M | 12.7% |
| 5 | $55.93 | 24,401 | $1.4M | 12.3% |
| 6 | $55.93 | 24,401 |
| $1.4M |
| 12.3% |
| 7 | $55.94 | 24,403 | $1.4M | 12.3% |
| 8 | $55.94 | 24,403 | $1.4M | 12.3% |
| Total | $55.70 avg | 200,000 | $11.1M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |